Discovering patients with AI 

#1

literature review tech worldwide*

*StartusInsight 2023

Patient profiles

enriched with 100 billion datapoints

Logo imageLogo imageLogo imageLogo imageLogo imageLogo image

We enable patient centricity with cuttting-edge data

Learn about our AI models

Since 2018, ArcaScience has been building artificial intelligent models to consolidate original patient-centric information helping clinicians and safety specialists to deliver better drugs at scale.

Today, we provide the first comprehensive Patient Centric database in the world and tailored reports to build & maintain safer, more efficient treatments

Our solutions

Streamlining data into safer & more efficient drugs

A.S Trial Balancer

AI-assisted benefit-risk prediction - What if one could diferenciate the most promising drugs from the others, before reaching clinical trials? In 2023, it was made possible and had a critical impact multiple-sclerosis patients.

Read more

A.S Safety Shield

Safety Monitoring Report- Safety issues can go unnoticed buried in a sea of data, jeopardizing patient safety. What if you can monitor everything?

Read more

A.S Trial Designer

AI-assisted endpoint discovery- Feeling overwhelmed by the "COA Maze"? Clinical endpoints or Clinical Outcome Assessments (COAs) are essential for any clinical trial, but choosing the wrong one can derail an entire project.

Read more

A.S KOL Finder

AI-assisted KOL identification - Recruitments are not enough targeted, resulting in severely delayed clinical trials. What if AI had proven its efficiency at bringing the most critical trials at the doorstep of these patients?

Read more

A.S Therapeutic Horizon

1 location, 1 search engine, all your data for a simplified and improved literature review

Read more

A.S Trial Scanner

Integrate any data into your eCRF and discover instantly how to handle your real-world studies

Read more

Our Shop

Buy your own comprehensive, quick and foolproof analysis
For safety specialists
Safety report

per drug

icon

Adverse events mentions

icon

Patient profiles

icon

Bibliography

icon

Over the last month

icon

Weekly update available

Get started
For clinical trial leaders
Endpoint study

per pathology

icon

Top endpoint (COAs)

icon

Top PROMs, PerfOs & ClinROs

icon

Top endpoint per drugs

icon

Composite  outcomes

icon

Comprehensive CSV with endpoints since 1960

For clinial trial leaders
KOL 
study

per pathology

icon

HCPs KOL

icon

Insitutional affiliations

icon

Institutional collaborations

icon

Similar populations investigated

icon

Top and surging KOLs

For drug design specialists
Target study

per target

icon

Safety issues

icon

Biomarker mentions

icon

Population screening

icon

Drug mentions

icon

Target mentions

For Benefit-risk management
Benefit-risk study

On-demand

icon

Risk analysis

icon

Efficacy analysis

icon

Predictive benefit-risk value tree

icon

Comprehensive data integration

icon

Competitor's drug benefit-risk value tree

More info about our studies

Change the way you work, with our studies

Endpoint report

A single endpoint report to discover the most promising COAs, PROms, ClinROs on a single pathology

services image

Benefit-risk report

Elevate your drug development process with the Benefit-Risk Prediction Report by ArcaScience. This report provides critical insights to predict the benefit-risk profile of drugs at the earliest stages, allowing for informed decision-making and de-risking clinical trials.

services image

KOL report

Our KOL report delivers readily accessible, accurate, and secured recruitment sites data and exclusive analytics directly linked to your specific trial's pathology and targeted patient population.

services image

Safety Monitoring Report

A.S SafetyShield report, empower drug safety specialists with superior AI-driven insights for informed signal detection

services image
Logo image
Logo image
Logo image
Logo image
Logo image
Logo image
tooltipmaplocatorlocatorlocatorlocatorlocator